Adient (NYSE:ADNT) Price Target Lowered to $17.00 at Morgan Stanley
Adient (NYSE:ADNT – Get Free Report) had its price target decreased by Morgan Stanley from $19.00 to $17.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 20.32% from the company’s previous close. ADNT […]
